Calcium Pantothenate PDE report and OEL report profile
Project-specific health-based exposure limit and occupational toxicology assessment support. The agreed scope may include PDE/ADE derivation, OEL derivation and OEB/OHC banding, based on the exact substance form, available evidence and intended product or workplace context.
CAS Registry Number
137-08-6
Molecular formula
C18H32CaN2O10
Molecular weight
476.5 g/mol
Drug class
Calcium salt of pantothenic acid (vitamin B5)nutritional vitamin
Mechanism of action
Provides pantothenate, a precursor for coenzyme A and acyl carrier protein, required for fatty-acid synthesis and oxidation and numerous acyl-transfer reactions in intermediary metabolism. Calcium is a counter-ion and nutrient contributor.
Indications / reported uses
Prevention and treatment of pantothenic acid deficiency and nutritional supplementation; no general therapeutic indication for unrelated conditions should be inferred from pantothenate biochemical function
Scope is agreed for the exact substance form, intended use, exposure route, workplace context and available toxicological evidence.
PDE/ADE: critical effects, point of departure and justified adjustment factors.
OEL: inhalation hazards, exposure duration and workplace conditions.
OEB/OHC: evidence-based banding where requested; a band is not a numerical OEL.
Report: scientific rationale, source data, assumptions, uncertainties and limitations.
Assessment scope
PDE/ADE and OEL/OEB assessment
ReguSight provides project-specific support for Calcium Pantothenate PDE/ADE, OEL and OEB/OHC assessments. This combined profile covers the Calcium Pantothenate Permitted Daily Exposure (PDE) report (the Calcium Pantothenate PDE report); Acceptable Daily Exposure (ADE) is the corresponding health-based daily exposure terminology. It also covers the Calcium Pantothenate Occupational Exposure Limit (OEL) report (the Calcium Pantothenate OEL report). PDE/ADE derivation and workplace exposure assessment are distinct scientific outputs; a band is not a numerical OEL.
Assessment may cover
PDE/ADE derivation using relevant toxicological evidence, critical effects, a justified point of departure and adjustment factors.
The EMA HBEL guideline informs PDE/ADE assessments in relevant shared-facility contexts. ECHA and HSE sources address workplace exposure limits; NIOSH provides occupational exposure-banding guidance. The applicable framework depends on the assessment question and jurisdiction.